The University of Sydney
spcr
spcr
spcr
spcr
spcr
Large text
spcr
Default text
spcr

Sir Zelman Cowen Universities Fund Alzheimer's Disease Research Grants

Since its establishment in 1978, the Sir Zelman Cowen Universities Fund has raised funds for medical and scientific research focused on finding therapies for still-incurable diseases.

Since the launch of its Alzheimer's Disease & Inflammation Initiative in 1996, the Fund has supported research aimed at finding the cause and a potential cure, for the dementia of Alzheimer's disease (AD).

Following this interest, in May 2008, the Trustees of the Fund announced the establishment of the Sir Zelman Cowen Universities Fund Alzheimer's Disease Research Grant for a research project in the field of Alzheimer's disease, where the aim of the project was to develop and/or assess new treatments for this condition. Applications were open to permanent members of staff of the University of Sydney and the Hebrew University of Jerusalem. Joint applications for cooperative projects between permanent members of staff of both universities were also welcomed.

The grant of $100,000 over 2 years was awarded to Dr Claire Goldsbury, Brain & Mind Research Institute, University of Sydney and Dr Karen Cullen, Discipline of Anatomy & Histology, University of Sydney for their project entitled, Energy deficiency as a cause of neuritic pathology in Alzheimer's Disease. You can read about this project and its outcomes here.

This grant program has been followed in 2014, by the The SZCUF Grant for Novel Approaches to Therapy in Alzheimer's Disease. It aims to encourage novel approaches to therapy for Alzheimer’s disease (AD). While open to individual applicants from both the University of Sydney and the Hebrew University of Jerusalem, the grant encourages applications for joint projects from scientists of the two Universities and gives preference to these.

The grant of $250,000 over 2 years has been awarded to Professor Yuval Dor, Hadassah Medical School, Dept of Developmental Biology and Cancer Research for his project titled Non-invasive measurement of neuronal cell death. You can read about this project here.